Of note, in 2016 the World Health Organization classification included myeloid malignancies arising from germline mutations in ANKRD26, RUNX1, and ETV6 into a new category defined as “Myeloid neoplasms with germline predisposition and pre-existing platelet disorders” [1]. The gene discussed is ETV6; the disease is myeloid neoplasm.